This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Patient Safety/ Medical Error  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Intern Med. 1998;158:941-942.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTEREST IN Alzheimer disease (AD) has increased dramatically during the past 2 decades. Previously, AD was considered by many to be a presenile dementia, whereas senility was often ascribed to aging per se. We now know that AD is the most common cause of dementia in the elderly, with typical onset occurring between the ages of 75 and 85 years. The news created by the public announcement that Ronald Reagan, a popular former president, had been diagnosed as having AD signaled the intense public interest in the disease.

The increased interest in AD was accompanied by increased research activity and a better understanding of the disease. Our knowledge of both the clinical and pathophysiological nature of AD has increased in the past 15 years. Management strategies have improved. However, pharmacological treatments previously have enjoyed little success. Popular treatments, including vasodilators and ergoloid mesylates,¹ along with experimental treatments based on theories . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Donepezil Improves Cognition and Global Function in Alzheimer Disease: A 15-Week, Double-blind, Placebo-Controlled Study
Sharon L. Rogers, Rachelle S. Doody, Richard C. Mohs, Lawrence T. Friedhoff, and and the Donepezil Study Group
Arch Intern Med. 1998;158(9):1021-1031.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alzheimer's disease and other dementias: A review
Rogan and Lippa
AM J ALZHEIMERS DIS OTHER DEMEN 2002;17:11-17.
ABSTRACT  

An 80-Year-Old Man With Memory Loss
Larson
JAMA 2000;283:1046-1053.
FULL TEXT